Nadir Yehya

Children'S Hosp Of Philadelphia

$8,035,301

Attributed

$9,005,213

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.3M · FY2017–25

$2.5M$1.9M$1.3M$625K$0

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$9,005,213 · 5

By mechanism

R01$8,311,518 · 4

K23$693,695 · 1

Top collaborators

Most similar at Children'S Hosp Of Philadelphia

Same institution · by research overlap

Stella T Chou$21,048,327
Gregory Edward Tasian$7,559,026
Sriram Krishnaswamy$22,716,630
Scott L Weiss$5,440,217
Frances B Balamuth$3,775,956

Others in their field

Other Emerging Leaders on “Mortality”

Chanza Baytop · Westat, Inc.$271,217,917
Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
Greg Witham · Anp Technologies, Inc.$19,727,817
Yunda Huang · Fred Hutchinson Cancer Center$19,033,873
Barbara Halina Braffett · George Washington University$17,931,151

Research focus

MortalityAdultUnited StatesChildHourEpidemiologyPlasmaSupportive CareChildhoodSyndromeSepsisLinkSepticInnovationFutureTargeted TreatmentSubgroupPhiladelphiaBiological MarkersPediatric HospitalsPhenotypeHypoxemiaMortality RiskGuidelines

Grant awards (15)

Lung Injury in ONcologic Stem cell transplants (LIONS)$879,567

R01 · FY2025 · HL · contact PI

Pediatric Acute Respiratory distress syndrome MAnagement (PARMA)$767,069

R01 · FY2025 · HD · contact PI

Finding Appropriate Subtypes in a Trial of Balanced versus nOrmaL Saline FlUid in Sepsis$622,662

R01 · FY2025 · GM · contact PI

Finding Appropriate Subtypes in a Trial of Balanced versus nOrmaL Saline FlUid in Sepsis$667,907

R01 · FY2024 · GM · contact PI

Linking Endotypes and Outcomes in Pediatric Acute Respiratory Distress Syndrome$735,125

R01 · FY2023 · HL · contact PI

Finding Appropriate Subtypes in a Trial of Balanced versus nOrmaL Saline FlUid in Sepsis$666,306

R01 · FY2023 · GM · contact PI

Linking Endotypes and Outcomes in Pediatric Acute Respiratory Distress Syndrome$784,307

R01 · FY2022 · HL · contact PI

Finding Appropriate Subtypes in a Trial of Balanced versus nOrmaL Saline FlUid in Sepsis$655,729

R01 · FY2022 · GM · contact PI

Linking Endotypes and Outcomes in Pediatric Acute Respiratory Distress Syndrome$815,360

R01 · FY2021 · HL · contact PI

Linking Endotypes and Outcomes in Pediatric Acute Respiratory Distress Syndrome$831,661

R01 · FY2020 · HL · contact PI

Clinical and Proteomic Characterization of Nucleosomes in Pediatric Acute Respiratory Distress Syndrome$147,931

K23 · FY2020 · HL · contact PI

Linking Endotypes and Outcomes in Pediatric Acute Respiratory Distress Syndrome$885,825

R01 · FY2019 · HL · contact PI

Clinical and Proteomic Characterization of Nucleosomes in Pediatric Acute Respiratory Distress Syndrome$182,088

K23 · FY2019 · HL · contact PI

Clinical and Proteomic Characterization of Nucleosomes in Pediatric Acute Respiratory Distress Syndrome$181,944

K23 · FY2018 · HL · contact PI

Clinical and Proteomic Characterization of Nucleosomes in Pediatric Acute Respiratory Distress Syndrome$181,732

K23 · FY2017 · HL · contact PI